Aspirin and Extended-Release Dipyridamole Capsules — Class III drug recall D-1282-2022
Ongoing recall by Glenmark Pharmaceuticals Inc., USA, reported 2022-07-27, distributed nationwide. Failed Tablet/Capsule Specification : Capsule breakage
| Recall number | D-1282-2022 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, United States |
| Recall initiated | 2022-06-29 |
| Classified | 2022-07-18 |
| Reported by FDA | 2022-07-27 |
| Distributed | Nationwide (US) |
| Quantity | 168,936 bottles |
| Reason classes | device malfunction |
| NDC | 68462-0405, 68462-0405-30, 68462-0405-60 |
| Lot numbers | 17201639, 17201759, 17202067, 17210092, 17210145, 17210696, 17210732, 17211062, 17211441, 17211670, 17211810, 17211862, 17212020, 17212068, 17212438, 17220172, 17220251 |
| Expiration dates | 2022-08, 2022-09, 2022-10, 2022-11, 2022-12, 2023-02, 2023-04, 2023-05, 2023-06, 2023-07, 2023-08, 2023-10, 2023-12 |
Product
Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200 mg, 60-count bottle, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-405-60.
Reason for recall
Failed Tablet/Capsule Specification : Capsule breakage
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1282-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.